Every day 12 new people in Denmark are diagnosed with epilepsy
Epilepsy is a chronic state of the brain, characterized by seizure occurrence. It is one of the most common neurological disorders, affecting more than 50 million people worldwide and approx. 50,000 people in Denmark.
Who is most at risk for epilepsy?
Epilepsy can occur at any age but is most common in children during the first years of life and in adults over 65 years due to, for example, brain trauma, tumors, and strokes.
Epilepsy is a diagnosis with very different consequences for the individual. According to WHO and our experience, 70% of patients can become seizure-free and in more than 90% of patients, seizures can be well controlled, significantly increasing the quality of life, if properly diagnosed and treated. But the prognosis depends a lot on the cause of epilepsy and how soon a patient gets the right treatment. The basic tools of model medicine against epilepsy are anti-epileptic drugs – there are over 20 kinds – and neurosurgery.
Denmark does not comply with international recommendations: 11 years of wait vs 2 years
Every 3rd epilepsy patient cannot become seizure-free using epilepsy medication. This is where surgery can help. After the surgery most patients feel better, take less medication, and have significantly fewer visits to the doctor. Unfortunately, in Denmark patients who finally get a referral for surgery have on average been through 11 years (!!!) of unsuccessful medical treatment with 6 different anti-epileptic drugs before it. This shows the study conducted by Lars Pinborg, the leader of the Danish epilepsy surgery program.
According to Lars Pinborg, this is far more than the international recommendations suggest. The recommendations are that patients should be referred for epilepsy surgery within two years after the medication could not make the patient seizure-free. The chairman of the Epilepsy Association also adds that a significant part of the problem is because too few people are referred to specialized medical care as soon as the medical treatment proves to be insufficient. Additionally, those who agree to an operation, among other things, experience a long waiting time for further examinations and surgery itself.
The Epilepsy Association’s conclusion is that investigation for epilepsy treatment with surgery and VNS implantation is way too slow, the path of the patient in the Danish health system is too long. And thus it costs way too much for individuals with epilepsy (in terms of time, health, opportunities, and their ability to have an adequate social life), their nearest circle, and for society.
How MedCare Ukraine can help
We partner with specialized epilepsy centers in Europe. Therefore we can ensure quick access for our patients to the right medical care featuring individual approach, cutting-edge technology for diagnosis and drug treatment & neurosurgical support. All this helps to achieve optimal seizure control for patients in the short term and consequently improves the quality of life of adults and children suffering from epilepsy.
The objectives of a tailored to a single patient epilepsy treatment in such centers are:
– to provide a data-based evaluation towards a reliable diagnosis
– to determine the individualized drug-management scheme
– to explain to parents and relatives the particularities of each condition
– to indicate if a patient is a potential candidate for surgery
– to perform the pre-surgical evaluation
– to perform epilepsy surgery
– to monitor and manage the patients post-surgically
The scientific and clinically multidisciplinary approach of the epilepsy program provides the patient with the utmost modern medical knowledge following internationally approved procedures in the epilepsy treatment field.
Let us help you to manage your epilepsy. Contact us today to book your free initial consultation with the specialist.
Data source: Epilepsy Association, Denmark